Live Attenuated Vaccines Market Report

China Live Attenuated Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Sep 20, 2023
  • PAGES：230
  • REPORT CODE：GMM1811093
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

    Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

    This report elaborates on the current development of the Live Attenuated Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Sanofi

    • CSL

    • GlaxoSmithKline

    • Johnson & Johnson

    • Astellas Pharma

    • Merck

    By Type:

    • Bacterial

    • Viral

    By Application:

    • Hospitals

    • Clinics

    • Research Institutes

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Live Attenuated Vaccines Market Overview 2018-2029

    • 1.1 China Live Attenuated Vaccines Industry Development Overview

    • 1.2 China Live Attenuated Vaccines Industry Development History

    • 1.3 China Live Attenuated Vaccines Industry Market Size (2018-2029)

    • 1.4 China Live Attenuated Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Live Attenuated Vaccines Production Volume, Production Value and Growth Rate of Bacterial (2018-2029)

      • 1.4.2 China Live Attenuated Vaccines Production Volume, Production Value and Growth Rate of Viral (2018-2029)

    • 1.5 China Live Attenuated Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.3 China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Research Institutes (2018-2029)

      • 1.5.4 China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Live Attenuated Vaccines Market Analysis by Region

      • 1.6.1 North China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Live Attenuated Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Live Attenuated Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Live Attenuated Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Live Attenuated Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Live Attenuated Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Live Attenuated Vaccines Industry Development

    Chapter 3 Live Attenuated VaccinesIndustry Chain Analysis

    • 3.1 Live Attenuated Vaccines Industry Chain

    • 3.2 Live Attenuated Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Live Attenuated Vaccines Market

    • 3.3 Live Attenuated Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Live Attenuated Vaccines Market

    Chapter 4 China Live Attenuated Vaccines Market, by Type

    • 4.1 China Live Attenuated Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Live Attenuated Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Live Attenuated Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Live Attenuated Vaccines Production Volume and Growth Rate of Bacterial

      • 4.5.2 China Live Attenuated Vaccines Production Volume and Growth Rate of Viral

    Chapter 5 China Live Attenuated Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Live Attenuated Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Live Attenuated Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Live Attenuated Vaccines Market Size and Growth Rate of Hospitals

      • 5.5.2 China Live Attenuated Vaccines Market Size and Growth Rate of Clinics

      • 5.5.3 China Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes

      • 5.5.4 China Live Attenuated Vaccines Market Size and Growth Rate of Others

    Chapter 6 China Live Attenuated Vaccines Market, by Region

    • 6.1 China Live Attenuated Vaccines Production Volume and Production Value, by Region

    • 6.2 China Live Attenuated Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Live Attenuated Vaccines Market Analysis

    • 7.1 North China Live Attenuated Vaccines Market, by Type

    • 7.2 North China Live Attenuated Vaccines Market, by Application

    Chapter 8 Central China Live Attenuated Vaccines Market Analysis

    • 8.1 Central China Live Attenuated Vaccines Market, by Type

    • 8.2 Central China Live Attenuated Vaccines Market, by Application

    Chapter 9 South China Live Attenuated Vaccines Market Analysis

    • 9.1 South China Live Attenuated Vaccines Market, by Type

    • 9.2 South China Live Attenuated Vaccines Market, by Application

    Chapter 10 East China Live Attenuated Vaccines Market Analysis

    • 10.1 East China Live Attenuated Vaccines Market, by Type

    • 10.2 East China Live Attenuated Vaccines Market, by Application

    Chapter 11 Northeast China Live Attenuated Vaccines Market Analysis

    • 11.1 Northeast China Live Attenuated Vaccines Market, by Type

    • 11.2 Northeast China Live Attenuated Vaccines Market, by Application

    Chapter 12 Southwest China Live Attenuated Vaccines Market Analysis

    • 12.1 Southwest China Live Attenuated Vaccines Market, by Type

    • 12.2 Southwest China Live Attenuated Vaccines Market, by Application

    Chapter 13 Northwest China Live Attenuated Vaccines Market Analysis

    • 13.1 Northwest China Live Attenuated Vaccines Market, by Type

    • 13.2 Northwest China Live Attenuated Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Live Attenuated Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sanofi

        • 14.2.1 Sanofi Company Profile

        • 14.2.2 Sanofi Live Attenuated Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 CSL

        • 14.3.1 CSL Company Profile

        • 14.3.2 CSL Live Attenuated Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline

        • 14.4.1 GlaxoSmithKline Company Profile

        • 14.4.2 GlaxoSmithKline Live Attenuated Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Johnson & Johnson

        • 14.5.1 Johnson & Johnson Company Profile

        • 14.5.2 Johnson & Johnson Live Attenuated Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Astellas Pharma

        • 14.6.1 Astellas Pharma Company Profile

        • 14.6.2 Astellas Pharma Live Attenuated Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck

        • 14.7.1 Merck Company Profile

        • 14.7.2 Merck Live Attenuated Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Live Attenuated Vaccines Industry Research Conclusions

    • 15.2 Live Attenuated Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Live Attenuated Vaccines Industry Market Size (2018-2029)

    • Figure China Live Attenuated Vaccines Production Volume, Production Value and Growth Rate of Bacterial (2018-2029)

    • Figure China Live Attenuated Vaccines Production Volume, Production Value and Growth Rate of Viral (2018-2029)

    • Figure China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Research Institutes (2018-2029)

    • Figure China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Live Attenuated Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Live Attenuated Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Live Attenuated Vaccines Market Share by Type in 2018

    • Figure China Live Attenuated Vaccines Market Share by Type in 2023

    • Figure China Live Attenuated Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Live Attenuated Vaccines Production Volume and Growth Rate of Bacterial (2018-2023)

    • Figure China Live Attenuated Vaccines Production Volume and Growth Rate of Viral (2018-2023)

    • Figure China Live Attenuated Vaccines Market Share by Application in 2018

    • Figure China Live Attenuated Vaccines Market Share by Application in 2023

    • Figure China Live Attenuated Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes (2018-2023)

    • Figure China Live Attenuated Vaccines Market Size and Growth Rate of Others (2018-2023)

    • Table China Live Attenuated Vaccines Production Volume by Region (2018-2023)

    • Table China Live Attenuated Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Live Attenuated Vaccines Production Volume Share by Region (2018-2023)

    • Table China Live Attenuated Vaccines Production Value by Region (2018-2023)

    • Table China Live Attenuated Vaccines Production Value Share by Region (2018-2023)

    • Figure China Live Attenuated Vaccines Production Value Share by Region (2018-2023)

    • Table China Live Attenuated Vaccines Sales Volume by Region (2018-2023)

    • Table China Live Attenuated Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Live Attenuated Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Live Attenuated Vaccines Sales Value by Region (2018-2023)

    • Table China Live Attenuated Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Live Attenuated Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table North China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table North China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table Central China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table South China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table South China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table East China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table East China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Live Attenuated Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Live Attenuated Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Live Attenuated Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Live Attenuated Vaccines Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)

    • Table CSL Company Profile

    • Table CSL Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Live Attenuated Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US